Ocular toxoplasmosis: in the storm of the eye

被引:48
作者
Jones, L. A. [1 ]
Alexander, J. [1 ]
Roberts, C. W. [1 ]
机构
[1] Univ Strathclyde, Dept Immunol, Strathlcyde Inst Biomed Sci, Glasgow G4 0NR, Lanark, Scotland
关键词
immune privilege; immunopathology; ocular toxoplasmosis;
D O I
10.1111/j.1365-3024.2006.00874.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ocular toxoplasmosis (OT) can occur in the children of mothers infected with Toxoplasma gondii during pregnancy. It is not limited to the congenitally infected, but can also occur following adult-acquired infection or as a result of disease reactivation in immune-compromised and pregnant individuals. Many aspects of immune privilege in the eye, including constitutive TGF-beta expression and reduced MHC class 1 expression, would appear at first to favour parasite survival. Conversely, many of the mechanisms that control parasite multiplication in other anatomical sites, such as nitric oxide expression, IFN-gamma and TNF-alpha, are known to disrupt immune privilege and are associated with ocular damage. Taking into account the opposing needs of limiting parasite multiplication and minimizing tissue destruction we review the pathogenesis of OT in the murine model.
引用
收藏
页码:635 / 642
页数:8
相关论文
共 54 条
[1]   INFLUENCE OF GENES WITHIN THE MHC ON MORTALITY AND BRAIN CYST DEVELOPMENT IN MICE INFECTED WITH TOXOPLASMA-GONDII - KINETICS OF IMMUNE REGULATION IN BALB H-2 CONGENIC MICE [J].
BLACKWELL, JM ;
ROBERTS, CW ;
ALEXANDER, J .
PARASITE IMMUNOLOGY, 1993, 15 (06) :317-324
[2]   Nitric oxide in parasitic infections [J].
Brunet, LR .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (08) :1457-1467
[3]   Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana [J].
Carme, B ;
Bissuel, F ;
Ajzenberg, D ;
Bouyne, R ;
Aznar, C ;
Demar, M ;
Bichat, S ;
Louvel, D ;
Bourbigot, AM ;
Peneau, C ;
Neron, P ;
Dardé, ML .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4037-4044
[4]   IL-10, an inflammatory/inhibitory cytokine, but not always [J].
Conti, P ;
Kempuraj, D ;
Kandere, K ;
Di Gioacchino, M ;
Barbacane, RC ;
Castellani, ML ;
Felaco, M ;
Boucher, W ;
Letourneau, R ;
Theoharides, TC .
IMMUNOLOGY LETTERS, 2003, 86 (02) :123-129
[5]  
D'Orazio TJ, 1998, J IMMUNOL, V160, P2089
[6]  
DAVIDSON MG, 1993, INVEST OPHTH VIS SCI, V34, P3653
[7]   THE ULTRASTRUCTURAL PATHOLOGY OF CONGENITAL MURINE TOXOPLASMIC RETINOCHOROIDITIS .2. THE MORPHOLOGY OF THE INFLAMMATORY CHANGES [J].
DUTTON, GN ;
MCMENAMIN, PG ;
HAY, J ;
CAMERON, S .
EXPERIMENTAL EYE RESEARCH, 1986, 43 (04) :545-560
[8]   TOXOPLASMOSIS IN IMMUNOGLOBULIN-M-SUPPRESSED MICE [J].
FRENKEL, JK ;
TAYLOR, DW .
INFECTION AND IMMUNITY, 1982, 38 (01) :360-367
[9]  
FRENKEL JK, 1967, J IMMUNOL, V98, P1309
[10]  
Friedrich R, 1992, Ger J Ophthalmol, V1, P54